In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study
- PMID: 35831914
- PMCID: PMC9349721
- DOI: 10.1002/jmv.27999
In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study
Conflict of interest statement
The authors declare no conflict of interest.
Comment in
-
"Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study": Author's reply.J Med Virol. 2023 Jan;95(1):e28151. doi: 10.1002/jmv.28151. Epub 2022 Sep 21. J Med Virol. 2023. PMID: 36109191 Free PMC article. No abstract available.
Comment on
-
Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study.J Med Virol. 2022 Oct;94(10):4762-4775. doi: 10.1002/jmv.27918. Epub 2022 Jun 14. J Med Virol. 2022. PMID: 35672249 Free PMC article.
References
-
- Boscolo‐Rizzo P, Hummel T, Hopkins C, et al. High prevalence of long‐term olfactory, gustatory, and chemesthesis dysfunction in post‐COVID‐19 patients: a matched case‐control study with one‐year follow‐up using a comprehensive psychophysical evaluation. Rhinology. 2021;59:517‐527. - PubMed
-
- Killingley B, Mann AJ, Kalinova M, et al. Safety, tolerability and viral kinetics during SARS‐CoV‐2 human challenge in young adults. Nat Med. 2022;28:1031‐1041. - PubMed
